This story has been updated and changed to reflect additional information from court documents and other public records.
NEW YORK – Oxford Nanopore Technologies has denied allegations by Pacific Biosciences that it has willfully infringed patents held by PacBio.
In court documents from two patent infringement suits, unsealed earlier this week, Oxford Nanopore Technologies also reiterated its request to invalidate four patents held by Pacific Biosciences and to dismiss the two lawsuits where PacBio has alleged infringement of those patents.